CD28 signals the differential control of regulatory T cells and effector T cells

European Journal of Immunology

Volumn 44, Issue 4, 2014, Pages 955-957

  Mikami, Norihisa ^a   Sakaguchi, Shimon ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

CD28; Immune suppression; Regulatory T cells

Indexed keywords

CD28 ANTIGEN; CORTICOSTEROID; INTERLEUKIN 10 ANTIBODY;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE SYNDROME; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

CD28; IMMUNE SUPPRESSION; REGULATORY T CELLS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD28; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, REGULATORY;

EID: 84898013719     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444513     Document Type: Note

References (25)

1. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M., Regulatory T cells and immune tolerance. Cell 2008. 133: 775-787.
2. Hilbrands, R., Howie, D., Cobbold, S. and Waldmann, H., Regulatory T cells and transplantation tolerance. Immunotherapy 2013. 5: 717-731.
3. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J. et al., Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 1998. 10: 1969-1980.
4. Lin, C. H. and Hünig, T., Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol. 2003. 33: 626-638.
5. Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D. and Panoskaltsis, N., Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 2006. 355: 1018-1028.
6. + effector memory T cells. Br. J. Pharmacol. 2010. 161: 512-526.
7. Römer, P. S., Berr, S., Avota, E., Na, S. Y., Battaglia, M., ten Berge, I., Einsele, H. et al., Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood 2011. 118: 6772-6782.
8. Tabares, P., Berr, S., Römer, P. S., Chuvpilo, S., Matskevich, A. A., Tyrsin, D., Fedotov, Y. et al., Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08. Eur. J. Immunol. 2014. 44: 1225-1236.
9. Gogishvili, T., Langenhorst, D., Lühder, F., Elias, F., Elflein, K., Dennehy, K. M., Gold, R. and Hünig, T., Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. PLoS One 2009. 4: e4643.
10. Pandolfi, J., Baz, P., Fernández, P., Lupi, A., Payaslián, F., Billordo, L. A., Fainboim, L. et al., Regulatory and effector T-cells are differentially modulated by Dexamethasone. Clin. Immunol. 2013. 149: 400-410.
11. Rudd, C. E. and Schneider, H., Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 2003. 3: 544-556.
12. Ladygina, N., Gottipati, S., Ngo, K., Castro, G., Ma, J. Y., Banie, H., Rao, T. S. et al., PI3Kγ kinase activity is required for optimal T-cell activation and differentiation. Eur. J. Immunol. 2013. 43: 3183-3196.
13. Sester, U., Wabnitz, G. H., Kirchgessner, H. and Samstag, Y., Ras/PI3kinase/cofilin-independent activation of human CD45RA+ and CD45RO+ T cells by superagonistic CD28 stimulation. Eur. J. Immunol. 2007. 37: 2881-2891.
14. Kalland, M. E., Oberprieler, N. G., Vang, T., Taskén, K. and Torgersen, K. M., T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells. J. Immunol. 2011. 187: 5233-5245.
15. Vaeth, M., Gogishvili, T., Bopp, T., Klein, M., Berberich-Siebelt, F., Gattenloehner, S., Avots, A. et al., Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proc. Natl. Acad. Sci. USA 2011. 108: 2480-2485.
16. Borlikova, G. and Endo, S., Inducible cAMP early repressor (ICER) and brain functions. Mol. Neurobiol. 2009. 40: 73-86.
17. Du, K. and Montminy, M., CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 1998. 273: 32377-32379.
18. Wang, J. M., Chao, J. R., Chen, W., Kuo, M. L., Yen, J. J. and Yang-Yen, H. F., The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell. Biol. 1999. 19: 6195-6206.
19. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S. et al., Regulation of cell death protease caspase-9 by phosphorylation. Science 1998. 282: 1318-1321.
20. del Peso, L., González-García, M., Page, C., Herrera, R. and Nuñez, G., Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997. 278: 687-689.
21. Kim, A. H., Khursigara, G., Sun, X., Franke, T. F. and Chao, M. V., Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 2001. 21: 893-901.
22. Tischner, D., Gaggl, I., Peschel, I., Kaufmann, M., Tuzlak, S., Drach, M., Thuille, N. et al., Defective cell death signalling along the Bcl-2 regulated apoptosis pathway compromises Treg cell development and limits their functionality in mice. J. Autoimmun. 2012. 38: 59-69.
23. Pierson, W., Cauwe, B., Policheni, A., Schlenner, S. M., Franckaert, D., Berges, J., Humblet-Baron, S. et al., Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3 regulatory T cells. Nat. Immunol. 2013. 14: 959-965.
24. NEG. Eur. J. Immunol. 2012. 42: 1893-1905.
25. Bouguermouh, S., Fortin, G., Baba, N., Rubio, M. and Sarfati, M., CD28 down regulates Th17 development. PLoS One 2009. 4: e5087.